FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Potter

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Concepts & Ideas

Psychiatric Status Rating Scales

Anatomy

Brain

Co-author Network

Publications

TOP 3
Ayşegül Ozerdem; Mark E Schmidt; Husseini K Manji; Robert C Risinger; William Z Potter
Chronic lithium administration enhances noradrenergic responses to intravenous administration of the alpha2 antagonist idazoxan in healthy volunteers.
Mark E Schmidt; R J Oshinsky; H G Kim; JL Schouten; B S Folley; William Z Potter
Cerebral glucose metabolic and plasma catecholamine responses to the alpha(2) adrenoceptor antagonist ethoxyidazoxan given to healthy volunteers.
Mark E Schmidt; R C Risinger; R L Hauger; JL Schouten; M Henry; William Z Potter
Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Potter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Ayşegül Ozerdem; Mark E Schmidt; Husseini K Manji; Robert C Risinger; William Z Potter
Chronic lithium administration enhances noradrenergic responses to intravenous administration of the alpha2 antagonist idazoxan in healthy volunteers.
Journal of clinical psychopharmacology 2004;24(2):150-4.
1999: Mark E Schmidt; R J Oshinsky; H G Kim; JL Schouten; B S Folley; William Z Potter
Cerebral glucose metabolic and plasma catecholamine responses to the alpha(2) adrenoceptor antagonist ethoxyidazoxan given to healthy volunteers.
Psychopharmacology 1999;146(2):119-27.
1997: Mark E Schmidt; R C Risinger; R L Hauger; JL Schouten; M Henry; William Z Potter
Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers.
Psychoneuroendocrinology 1997;22(3):177-88.
1997: Mark E Schmidt; John A Matochik; David S Goldstein; JL Schouten; Alan J Zametkin; William Z Potter
Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(4):298-310.
1997: William Z Potter; Mark E Schmidt
Treatment of major depression: selection of initial drug.
Modern problems of pharmacopsychiatry 1997;25():1-16.
1997: Mark E Schmidt; David S Goldstein; JL Schouten; John A Matochik; H G Kim; William Z Potter
Acute alpha 2 blockade by idazoxan increases insulin and lowers plasma glucose during positron emission tomography.
Psychopharmacology bulletin 1997;33(2):253-9.
1996: Guang Chen; B Pan; D B Hawver; Clinton Wright; William Z Potter; Husseini K Manji
Attenuation of cyclic AMP production by carbamazepine.
Journal of neurochemistry 1996;67(5):2079-86.
1996: Husseini K Manji; Y Bersudsky; Guang Chen; R H Belmaker; William Z Potter
Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):370-81.
1996: Guang Chen; Husseini K Manji; Clinton Wright; D B Hawver; William Z Potter
Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(3):271-80.
1996: Mark E Schmidt; Monique Ernst; John A Matochik; J M Maisog; B S Pan; Alan J Zametkin; William Z Potter
Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(7):1142-9.
1996: R E Litman; TP Su; William Z Potter; W W Hong; DAVID PICKAR
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
The British journal of psychiatry : the journal of mental science 1996;168(5):571-9.
1996: F Xavier Castellanos; J Elia; Markus Kruesi; WL Marsh; Charles S Gulotta; William Z Potter; G F Ritchie; SD Hamburger; Judy Rapoport
Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;14(2):125-37.
1996: Husseini K Manji; Guang Chen; J K Hsiao; E D Risby; M I Masana; William Z Potter
Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
The Journal of clinical psychiatry 1996;57 Suppl 13():34-46; discussion 47-8.
1996: William Z Potter
Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action.
The Journal of clinical psychiatry 1996;57 Suppl 4():4-8.
1995: K Suyama; K Saito; Guang Chen; B S Pan; Husseini K Manji; William Z Potter
Alterations in cyclic AMP generation and G protein subunits following transient ischemia in gerbil hippocampus.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1995;15(5):877-85.
1995: Husseini K Manji; William Z Potter; RH Lenox
Signal transduction pathways. Molecular targets for lithium's actions.
Archives of general psychiatry 1995;52(7):531-43.
1995: Mark E Schmidt; John A Matochik; R C Risinger; JL Schouten; Alan J Zametkin; Robert M Cohen; William Z Potter
Regional brain glucose metabolism after acute alpha 2-blockade by idazoxan.
Clinical pharmacology and therapeutics 1995;57(6):684-95.
1995: Husseini K Manji; Guang Chen; H Shimon; J K Hsiao; William Z Potter; R H Belmaker
Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment.
Archives of general psychiatry 1995;52(2):135-44.
1995: JOSE BITRAN; Husseini K Manji; William Z Potter; F Gusovsky
Down-regulation of PKC alpha by lithium in vitro.
Psychopharmacology bulletin 1995;31(2):449-52.
1994: Guang Chen; Husseini K Manji; D B Hawver; Clinton Wright; William Z Potter
Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro.
Journal of neurochemistry 1994;63(6):2361-4.
1994: Margaret Altemus; Susan E Swedo; Henrietta L Leonard; D Richter; David Rubinow; William Z Potter; Judy Rapoport
Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
Archives of general psychiatry 1994;51(10):794-803.
1994: F Xavier Castellanos; J Elia; Markus Kruesi; Charles S Gulotta; I N Mefford; William Z Potter; G F Ritchie; Judy Rapoport
Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder.
Psychiatry research 1994;52(3):305-16.
1994: K Suyama; K H Dykstra; M I Masana; Husseini K Manji; William Z Potter
In vivo evidence that nonneuronal beta-adrenoceptors as well as dopamine receptors contribute to cyclic AMP efflux in rat striatum.
Journal of neurochemistry 1994;62(5):1734-40.
1994: William Z Potter; Husseini K Manji
Catecholamines in depression: an update.
Clinical chemistry 1994;40(2):279-87.
1994: DAVID PICKAR; R E Litman; W W Hong; TP Su; E M Weissman; J K Hsiao; William Z Potter
Clinical response to clozapine in patients with schizophrenia.
Archives of general psychiatry 1994;51(2):159-60.
1994: M V Rudorfer; Husseini K Manji; William Z Potter
Comparative tolerability profiles of the newer versus older antidepressants.
Drug safety : an international journal of medical toxicology and drug experience 1994;10(1):18-46.
1994: William Z Potter
ECT methodologic issues.
Psychopharmacology bulletin 1994;30(3):455-9.
1993: R E Litman; W W Hong; E M Weissman; TP Su; William Z Potter; DAVID PICKAR
Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
Journal of clinical psychopharmacology 1993;13(4):264-7.
1993: William Z Potter; Husseini K Manji
Are monoamine metabolites in cerebrospinal fluid worth measuring?
Archives of general psychiatry 1993;50(8):653-6.
1993: J K Hsiao; J Colison; J J Bartko; A R Doran; P E Konicki; William Z Potter; DAVID PICKAR
Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Archives of general psychiatry 1993;50(8):606-14.
1993: William Z Potter; Terence A Ketter
Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1993;38(3 Suppl 2):S51-6.
1993: William Z Potter; Robert P Irwin
Methods to facilitate early exploratory testing of novel psychopharmacologic agents in humans.
Psychopharmacology series 1993;10():111-23.
1993: O T Osman; J K Hsiao; William Z Potter
Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humans.
Psychopharmacology 1993;111(3):295-300.
1993: J K Hsiao; William Z Potter; Hans Agren; R R Owen; DAVID PICKAR
Clinical investigation of monoamine neurotransmitter interactions.
Psychopharmacology 1993;112(1 Suppl):S76-84.
1992: Husseini K Manji; Guang Chen; JOSE BITRAN; F Gusovsky; William Z Potter
Idazoxan down-regulates beta-adrenoceptors on C6 glioma cells in vitro.
European journal of pharmacology 1992;227(3):275-82.
1992: M I Masana; JOSE BITRAN; J K Hsiao; William Z Potter
In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase in brain.
Journal of neurochemistry 1992;59(1):200-5.
1992: William Z Potter; Charles L Bowden
Valproate and mood disorders: perspectives. Introduction.
Journal of clinical psychopharmacology 1992;12(1 Suppl):2S-6S.
1992: J K Hsiao; Husseini K Manji; Guang Chen; J A Bitran; E D Risby; William Z Potter
Lithium administration modulates platelet Gi in humans.
Life sciences 1992;50(3):227-33.
1992: M V Rudorfer; Husseini K Manji; William Z Potter
Monoaminergic actions of ECT.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():677A-678A.
1992: Husseini K Manji; E D Risby; J K Hsiao; Guang Chen; William Z Potter
Effects of lithium on signal transduction in humans.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():608A-609A.
1992: William Z Potter; Husseini K Manji; Karon Dawkins; F Grossman
Combined measures of noradrenergic output and receptor responsivity in depression.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():319A-320A.
1992: William Z Potter; C Lindsay DeVane; M V Rudorfer
Steady-state predictions based on first dose data.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():239A-240A.
1992: Susan E Swedo; Henrietta L Leonard; Markus Kruesi; D C Rettew; Samuel J Listwak; Wade H Berrettini; M Stipetic; SD Hamburger; Philip W Gold; William Z Potter
Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.
Archives of general psychiatry 1992;49(1):29-36.
1991: O T Osman; C Lindsay DeVane; D J Greenblatt; William Z Potter
Pharmacokinetic and dynamic correlates of intravenous alprazolam challenge.
Clinical pharmacology and therapeutics 1991;50(6):656-62.
1991: William Z Potter; M V Rudorfer; Husseini K Manji
The pharmacologic treatment of depression.
The New England journal of medicine 1991;325(9):633-42.
1991: E D Risby; J K Hsiao; Husseini K Manji; J Bitran; F Moses; D F Zhou; William Z Potter
The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects.
Archives of general psychiatry 1991;48(6):513-24.
1991: Husseini K Manji; J K Hsiao; E D Risby; J Oliver; M V Rudorfer; William Z Potter
The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects.
Archives of general psychiatry 1991;48(6):505-12.
1991: Husseini K Manji; Guang Chen; J A Bitran; F Gusovsky; William Z Potter
Chronic exposure of C6 glioma cells to desipramine desensitizes beta-adrenoceptors, but increases KL/KH ratio.
European journal of pharmacology 1991;206(2):159-62.
1991: M V Rudorfer; M A Sherer; E A Lane; R N Golden; M Linnoila; William Z Potter
Acute noradrenergic effects of desipramine in depression.
Journal of clinical psychopharmacology 1991;11(1):22-7.
1991: M V Rudorfer; E D Risby; O T Osman; Philip W Gold; William Z Potter
Hypothalamic--pituitary--adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapy.
Biological psychiatry 1991;29(3):253-64.
1991: M I Masana; J A Bitran; J K Hsiao; I N Mefford; William Z Potter
Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study.
Brain research 1991;538(2):333-6.
1991: Karon Dawkins; William Z Potter
Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women.
Psychopharmacology bulletin 1991;27(4):417-26.
1991: Husseini K Manji; J A Bitran; M I Masana; Guang Chen; J K Hsiao; E D Risby; M V Rudorfer; William Z Potter
Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies.
Psychopharmacology bulletin 1991;27(3):199-208.
1991: Husseini K Manji; Guang Chen; J A Bitran; William Z Potter
Down-regulation of beta receptors by desipramine in vitro involves PKC/phospholipase A2.
Psychopharmacology bulletin 1991;27(3):247-53.
1990: J Elia; B G Borcherding; William Z Potter; I N Mefford; Judy Rapoport; C S Keysor
Stimulant drug treatment of hyperactivity: biochemical correlates.
Clinical pharmacology and therapeutics 1990;48(1):57-66.
1990: DAVID PICKAR; Alan Breier; J K Hsiao; A R Doran; Owen Wolkowitz; C N Pato; P E Konicki; William Z Potter
Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
Archives of general psychiatry 1990;47(7):641-8.
1990: Markus Kruesi; Judy Rapoport; SD Hamburger; E Hibbs; William Z Potter; Marge Lenane; G L Brown
Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents.
Archives of general psychiatry 1990;47(5):419-26.
1990: J A Bitran; William Z Potter; Husseini K Manji; F Gusovsky
Chronic Li+ attenuates agonist- and phorbol ester-mediated Na+/H+ antiporter activity in HL-60 cells.
European journal of pharmacology 1990;188(4-5):193-202.
1990: N S Buckholtz; D F Zhou; D X Freedman; William Z Potter
Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(2):137-48.
1990: William Z Potter; Husseini K Manji
Antidepressants, metabolites, and apparent drug resistance.
Clinical neuropharmacology 1990;13 Suppl 1():S45-53.
1989: M Koulu; N Bjelogrlic; Hans Agren; Juan M Saavedra; William Z Potter; M Linnoila
Diurnal variation in the concentrations of catecholamines and indoleamines in the median eminence and in the intermediate and posterior lobes of the pituitary gland of the male rat.
Brain research 1989;503(2):246-52.
1989: Susan E Swedo; Markus Kruesi; Henrietta L Leonard; SD Hamburger; D L Cheslow; M Stipetic; William Z Potter
Lack of seasonal variation in pediatric lumbar cerebrospinal fluid neurotransmitter metabolite concentrations.
Acta psychiatrica Scandinavica 1989;80(6):644-9.
1989: O T Osman; M V Rudorfer; William Z Potter
Idazoxan: a selective alpha 2-antagonist and effective sustained antidepressant in two bipolar depressed patients.
Archives of general psychiatry 1989;46(10):958-9.
1989: L J Fochtmann; Ricardo Cruciani; M Aiso; William Z Potter
Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra.
European journal of pharmacology 1989;167(2):305-6.
1989: M V Rudorfer; O T Osman; William Z Potter
Alprazolam and aggression.
The American journal of psychiatry 1989;146(7):949-50.
1989: J K Hsiao; J J Bartko; William Z Potter
Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry.
Archives of general psychiatry 1989;46(7):664-7.
1989: William Z Potter; J K Hsiao; S M Goldman
Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions.
Archives of general psychiatry 1989;46(6):558-62.
1989: I N Mefford; William Z Potter
A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation.
Medical hypotheses 1989;29(1):33-42.
1989: William Z Potter; M Linnoila
Biochemical classifications of diagnostic subgroups and D-type scores.
Archives of general psychiatry 1989;46(3):269-71.
1989: M Donnelly; Judy Rapoport; William Z Potter; J Oliver; C S Keysor; Dennis L Murphy
Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
Archives of general psychiatry 1989;46(3):205-12.
1989: K Saito; T Torda; William Z Potter; Juan M Saavedra
Characterization of beta 1- and beta 2-adrenoceptor subtypes in the rat sinoatrial node and stellate ganglia by quantitative autoradiography.
Neuroscience letters 1989;96(1):35-41.
1989: William Z Potter; G N Ko; L D Zhang; W W Yan
Clozapine in China: a review and preview of US/PRC collaboration.
Psychopharmacology 1989;99 Suppl():S87-91.
1989: William Z Potter; J K Hsiao; Hans Agren
Neurotransmitter interactions as a target of drug action.
Psychopharmacology series 1989;7():40-51.
1989: E D Risby; J K Hsiao; R N Golden; William Z Potter
Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.
Psychopharmacology 1989;99(4):508-14.
1988: Markus Kruesi; Susan E Swedo; SD Hamburger; William Z Potter; Judy Rapoport
Concentration gradient of CSF monoamine metabolites in children and adolescents.
Biological psychiatry 1988;24(5):507-14.
1988: K Saito; William Z Potter; Juan M Saavedra
Quantitative autoradiography of beta-adrenoceptors in the cardiac vagus ganglia of the rat.
European journal of pharmacology 1988;153(2-3):289-93.
1988: N S Buckholtz; A O Davies; M V Rudorfer; R N Golden; William Z Potter
Lymphocyte beta adrenergic receptor function versus catecholamines in depression.
Biological psychiatry 1988;24(4):451-7.
1988: N S Buckholtz; David T George; A O Davies; David C Jimerson; William Z Potter
Lymphocyte beta-adrenergic receptor modification in bulimia.
Archives of general psychiatry 1988;45(5):479-82.
1988: M Aiso; William Z Potter; Juan M Saavedra
Axonal transport of angiotensin-converting enzyme in the rat striatonigral pathway.
Brain research 1988;447(1):195-9.
1988: R N Golden; Sanford Markey; E D Risby; M V Rudorfer; R W Cowdry; William Z Potter
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
Archives of general psychiatry 1988;45(2):150-4.
1988: R N Golden; C L De Vane; Casey Laizure; M V Rudorfer; M A Sherer; William Z Potter
Bupropion in depression. II. The role of metabolites in clinical outcome.
Archives of general psychiatry 1988;45(2):145-9.
1988: R N Golden; M V Rudorfer; M A Sherer; M Linnoila; William Z Potter
Bupropion in depression. I. Biochemical effects and clinical response.
Archives of general psychiatry 1988;45(2):139-43.
1988: M V Rudorfer; E D Risby; J K Hsiao; M Linnoila; William Z Potter
ECT alters human monoamines in a different manner from that of antidepressant drugs.
Psychopharmacology bulletin 1988;24(3):396-9.
1988: K Saito; M Kurihara; Ricardo Cruciani; William Z Potter; Juan M Saavedra
Characterization of beta 1- and beta 2-adrenoceptor subtypes in the rat atrioventricular node by quantitative autoradiography.
Circulation research 1988;62(1):173-7.
1987: J K Hsiao; Hans Agren; J J Bartko; M V Rudorfer; M Linnoila; William Z Potter
Monoamine neurotransmitter interactions and the prediction of antidepressant response.
Archives of general psychiatry 1987;44(12):1078-83.
1987: M Aiso; William Z Potter; Juan M Saavedra
Axonal transport of dopamine D1 receptors in the rat brain.
Brain research 1987;426(2):392-6.
1987: E D Risby; J K Hsiao; Trey Sunderland; Hans Agren; M V Rudorfer; William Z Potter
The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
Clinical pharmacology and therapeutics 1987;42(5):547-54.
1987: M Aiso; K Shigematsu; J W Kebabian; William Z Potter; Ricardo Cruciani; Juan M Saavedra
Dopamine D1 receptor in rat brain: a quantitative autoradiographic study with 125I-SCH 23982.
Brain research 1987;408(1-2):281-5.
1985: M V Rudorfer; E A Lane; William Z Potter
Interethnic dissociation between debrisoquine and desipramine hydroxylation.
Journal of clinical psychopharmacology 1985;5(2):89-92.
1984: M V Rudorfer; E A Lane; W H Chang; M D Zhang; William Z Potter
Desipramine pharmacokinetics in Chinese and Caucasian volunteers.
British journal of clinical pharmacology 1984;17(4):433-40.
1984: William Z Potter; M V Rudorfer; E A Lane
Active metabolites of antidepressants: pharmacodynamics and relevant pharmacokinetics.
Advances in biochemical psychopharmacology 1984;39():373-90.